A Study to Investigate Multiple Ascending Doses of AZD5004 in Healthy Japanese Participants and Participants with Type 2 Diabetes Mellitus

Trial Identifier:	D7260C00003
Sponsor:	AstraZeneca
Start Date:	November 2024
Primary Completion Date:	March 2025
Study Completion Date:	March 2025
Condition:	Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
JP	Osaka-shi, JP, 532-0003

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.